.png){kind=icon}
返回
A novel multi-population coevolution immune optimization algorithm
.png){kind=icon}
PRE
AI
DOI：10.1007/s00500-015-1724-3.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
A novel multi-population coevolution immune optimization algorithm (MCIA) is proposed to solve numerical and engineering optimization problem in real world. MCIA is inspired by the mechanism that how neuroendocrine system affects T cells and B cells in immune system to eliminate the danger and the main idea of MCIA is to promote three populations, population B, population T and assistant population A, to coevolution through self-adjusted clone operator, the applied dislocation arithmetic crossover, cloud self-adapting mutation operator and local search operator to produce lymphocyte with high affinity. Self-adjusted clone operator and selecting elite elements in the memory population enable the search space be broadened and compressed, cloud self-adapting mutation operator characterized with randomness, stable topotaxis and local search technique enable global and local search be integrated to find the global optima with high population diversity. Therefore, several operators enable MCIA enjoy the capability of broadening the elite search space, boosting the global and local search around elites in search space. The performance comparisons of MCIA with three known immune algorithms and other three optimization algorithms in optimizing twelve benchmark functions indicate that MCIA is an effective algorithm for solving global optimization problems with high precision, good robustness and low time complexity.
Keyword:
Immune optimization algorithm
Neuroendocrine system
Cloud model
Coevolution
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
2.5
论文数:
1.0W
被引数:
2.1W
机构
引用论文
分享收藏分享收藏Information fusion for anomaly detection with the dendritic cell algorithm基于树突状细胞算法的信息融合异常检测.png)
INFORMATION FUSION
OAAI
INFORMATION FUSIONIF15.5
OAAI分享收藏Safety and immunogenicity of a recombinant DNA COVID-19 vaccine containing the coding regions of the spike and nucleocapsid proteins: Preliminary results from an open-label, phase 1 trial in healthy adults aged 19–55 years含刺突蛋白和核衣壳蛋白编码区域的重组DNA COVID-19疫苗的安全性与免疫原性：19-55岁健康成人开放标签I期试验的初步结果
OAAI
IF0
OAAI分享收藏Discovery of Novel HIV Protease Inhibitors Using Modern Computational Techniques利用现代计算技术研究新型HIV蛋白酶抑制剂的发现OAAI
OAAI分享收藏分享收藏
查看更多内容